EA200801302A1 - Композиции и способы лечения нарушений цнс - Google Patents
Композиции и способы лечения нарушений цнсInfo
- Publication number
- EA200801302A1 EA200801302A1 EA200801302A EA200801302A EA200801302A1 EA 200801302 A1 EA200801302 A1 EA 200801302A1 EA 200801302 A EA200801302 A EA 200801302A EA 200801302 A EA200801302 A EA 200801302A EA 200801302 A1 EA200801302 A1 EA 200801302A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- compositions
- methods
- cns disorders
- thienopyridinone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение в общем относится к тиенопиридиноновым модуляторам рецепторов 5-НТи в частности к применению этих соединений и их фармацевтических композиций, например, в лечении, модулировании и/или предотвращении физиологических состояний, связанных с действием серотонина, таких как, например, лечение болезни Альцгеймера, когнитивных расстройств, депрессии и беспокойства.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/271,019 US7598265B2 (en) | 2004-09-30 | 2005-11-10 | Compositions and methods for treating CNS disorders |
PCT/US2006/043140 WO2007058805A2 (en) | 2005-11-10 | 2006-11-06 | Compositions and methods for treating cns disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200801302A1 true EA200801302A1 (ru) | 2009-02-27 |
Family
ID=37946751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200801302A EA200801302A1 (ru) | 2005-11-10 | 2006-11-06 | Композиции и способы лечения нарушений цнс |
Country Status (17)
Country | Link |
---|---|
US (2) | US7598265B2 (ru) |
EP (1) | EP1959954A2 (ru) |
JP (1) | JP2009515877A (ru) |
KR (1) | KR20080067001A (ru) |
CN (1) | CN101340908A (ru) |
AR (1) | AR057887A1 (ru) |
AU (1) | AU2006315854A1 (ru) |
BR (1) | BRPI0618493A2 (ru) |
CA (1) | CA2629312C (ru) |
CR (1) | CR10062A (ru) |
EA (1) | EA200801302A1 (ru) |
IL (1) | IL191168A0 (ru) |
MA (1) | MA30037B1 (ru) |
NO (1) | NO20082679L (ru) |
TW (1) | TW200735868A (ru) |
WO (1) | WO2007058805A2 (ru) |
ZA (1) | ZA200804951B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) * | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US7407966B2 (en) * | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
NZ556761A (en) * | 2005-01-25 | 2011-04-29 | Galenea Corp | Substituted arylamine compounds and their use as 5-HT6 modulators |
GB0526258D0 (en) * | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
EP2445877B1 (en) * | 2008-12-03 | 2014-07-23 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
US8404711B2 (en) * | 2009-04-13 | 2013-03-26 | Theravance, Inc. | 5-HT4 receptor agonist compounds for treatment of cognitive disorders |
US20230139125A1 (en) * | 2021-02-04 | 2023-05-04 | Richard Natrillo | Dietary supplement for improving brain performance |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069412A (en) * | 1958-08-15 | 1962-12-18 | Fmc Corp | N-aminoazetidine and preparation thereof |
CA933923A (en) * | 1969-12-19 | 1973-09-18 | Eichenberger Kurt | Process for the manufacture of new thiopyranes |
GB1570494A (en) * | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
DE2925175A1 (de) * | 1979-06-22 | 1981-01-08 | Basf Ag | Verfahren zur herstellung von isatosaeureanhydriden |
IT1203323B (it) | 1987-02-02 | 1989-02-15 | Hoechst Italia Spa | Additivo fotoattivatore per composizioni polimeriche costituito dal sale metallico di una cera ossidata |
US5236917A (en) * | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
DE4008726A1 (de) | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno(2,3-d)pyrimidinderivate |
DE4023270A1 (de) * | 1990-07-21 | 1992-02-06 | Hoechst Ag | Hydrophile mischpolymere sowie deren verwendung in der reprographie |
US5219864A (en) | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5155115A (en) * | 1991-03-12 | 1992-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5227387A (en) * | 1991-09-03 | 1993-07-13 | Dowelanco | Quinoline nematicidal method |
DE4138820A1 (de) * | 1991-11-26 | 1993-05-27 | Basf Ag | Chinolin-3-carbonsaeureamide, deren herstellung und verwendung |
DE4208254A1 (de) * | 1992-03-14 | 1993-09-16 | Hoechst Ag | Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid |
DE4227747A1 (de) * | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
US5409948A (en) | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
JPH06239858A (ja) * | 1993-02-16 | 1994-08-30 | Otsuka Pharmaceut Co Ltd | 末梢血管拡張剤 |
GB9306460D0 (en) | 1993-03-29 | 1993-05-19 | Smithkline Beecham Plc | Novel compounds |
JPH07324087A (ja) * | 1994-04-04 | 1995-12-12 | Taisho Pharmaceut Co Ltd | 複素環化合物 |
TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
JP3829879B2 (ja) | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
DE19636769A1 (de) * | 1996-09-10 | 1998-03-12 | Basf Ag | 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
US6979309B2 (en) * | 1997-02-14 | 2005-12-27 | Nxstage Medical Inc. | Systems and methods for performing blood processing and/or fluid exchange procedures |
DE19724980A1 (de) * | 1997-06-13 | 1998-12-17 | Basf Ag | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
JPH11130777A (ja) | 1997-08-13 | 1999-05-18 | Takeda Chem Ind Ltd | チエノピリジン誘導体、その中間体およびそれらの製造法 |
DE69839887D1 (de) * | 1997-10-02 | 2008-09-25 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
US6103903A (en) * | 1998-02-26 | 2000-08-15 | Neurogen Corporation | 4-(4-piperidylmethyhlamino) substituted heteroaryl fused pyridines: GABA brain receptor ligands |
DE19815026A1 (de) * | 1998-04-03 | 1999-10-07 | Hoechst Schering Agrevo Gmbh | Substituierte Piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide |
WO1999051932A2 (en) * | 1998-04-08 | 1999-10-14 | Moshier Gary S | Launched munition neutralization of buried mines |
ID27600A (id) * | 1998-06-02 | 2001-04-12 | Osi Pharm Inc | KOMPOSISI PIROLO (2,3d) PIRIMIDIN DAN PENGGUNAANNYA |
US6232320B1 (en) * | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
JP2002542287A (ja) | 1999-04-28 | 2002-12-10 | レスピラトリウス アクチボラゲット | 医 薬 |
SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
JP3868811B2 (ja) | 1999-10-01 | 2007-01-17 | 大日本住友製薬株式会社 | 新規キナゾリン誘導体 |
EP1270568A1 (en) | 2001-06-19 | 2003-01-02 | Biofrontera Pharmaceuticals AG | 1-methyl-4-(3-ethoxy-9h-thioxanthene-ylidene)-piperidine and its use as 5-HT2B and/or H1 antagonist |
WO2003020728A1 (en) * | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
MXPA03000145A (es) | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
AU2003298514A1 (en) | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
US20040138238A1 (en) | 2002-08-08 | 2004-07-15 | Dhanoa Dale S. | Substituted aminopyrimidine compounds as neurokinin antagonists |
AU2003255845A1 (en) | 2002-08-22 | 2004-03-11 | Piramed Limited | Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
AU2003277215A1 (en) | 2002-10-01 | 2004-04-23 | Predix Pharmaceuticals Holdings, Inc. | Novel neurokinin antagonists and methods of use thereof |
US7153858B2 (en) * | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
ATE511511T1 (de) | 2003-03-31 | 2011-06-15 | Trovis Pharmaceuticals Llc | Neue piperidinylaminothienoä2,3-dü pyrimidinverbindungen |
US7119205B2 (en) * | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
BRPI0412919A (pt) * | 2003-07-25 | 2006-09-26 | Hoffmann La Roche | combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos |
GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
NZ546887A (en) * | 2003-11-03 | 2009-04-30 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US20060084806A1 (en) * | 2004-07-21 | 2006-04-20 | Ramasubramanian Sridharan | Processes for the preparation of imidazo[1,2-a] pyridine derivatives |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
NZ556761A (en) * | 2005-01-25 | 2011-04-29 | Galenea Corp | Substituted arylamine compounds and their use as 5-HT6 modulators |
JP2009520688A (ja) * | 2005-11-23 | 2009-05-28 | エピックス デラウェア, インコーポレイテッド | S1p受容体調節化合物およびそれらの使用 |
AR061637A1 (es) | 2006-06-26 | 2008-09-10 | Epix Delaware Inc | Composiciones y metodos de tratamiento de trastornos del snc |
WO2008045558A2 (en) | 2006-10-12 | 2008-04-17 | Epix Delaware, Inc. | Benzothiadiazine compounds and their use |
US8569259B2 (en) | 2006-11-17 | 2013-10-29 | Microdose Therapeutx, Inc. | Adenosine analogs and their use |
-
2005
- 2005-11-10 US US11/271,019 patent/US7598265B2/en active Active
-
2006
- 2006-11-06 KR KR1020087013812A patent/KR20080067001A/ko not_active Application Discontinuation
- 2006-11-06 JP JP2008540098A patent/JP2009515877A/ja active Pending
- 2006-11-06 BR BRPI0618493-6A patent/BRPI0618493A2/pt not_active IP Right Cessation
- 2006-11-06 AU AU2006315854A patent/AU2006315854A1/en not_active Abandoned
- 2006-11-06 EA EA200801302A patent/EA200801302A1/ru unknown
- 2006-11-06 EP EP06827533A patent/EP1959954A2/en not_active Ceased
- 2006-11-06 WO PCT/US2006/043140 patent/WO2007058805A2/en active Application Filing
- 2006-11-06 CN CNA2006800467370A patent/CN101340908A/zh active Pending
- 2006-11-06 CA CA2629312A patent/CA2629312C/en active Active
- 2006-11-09 AR ARP060104925A patent/AR057887A1/es not_active Application Discontinuation
- 2006-11-09 TW TW095141449A patent/TW200735868A/zh unknown
-
2008
- 2008-04-30 IL IL191168A patent/IL191168A0/en unknown
- 2008-06-06 ZA ZA200804951A patent/ZA200804951B/xx unknown
- 2008-06-06 MA MA31013A patent/MA30037B1/fr unknown
- 2008-06-10 NO NO20082679A patent/NO20082679L/no not_active Application Discontinuation
- 2008-06-10 CR CR10062A patent/CR10062A/es not_active Application Discontinuation
-
2009
- 2009-09-30 US US12/570,510 patent/US20110195953A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20082679L (no) | 2008-06-10 |
AR057887A1 (es) | 2007-12-26 |
AU2006315854A1 (en) | 2007-05-24 |
US20060234998A1 (en) | 2006-10-19 |
CA2629312C (en) | 2014-08-12 |
WO2007058805A2 (en) | 2007-05-24 |
US7598265B2 (en) | 2009-10-06 |
CR10062A (es) | 2009-05-14 |
JP2009515877A (ja) | 2009-04-16 |
CA2629312A1 (en) | 2007-05-24 |
US20110195953A1 (en) | 2011-08-11 |
TW200735868A (en) | 2007-10-01 |
KR20080067001A (ko) | 2008-07-17 |
CN101340908A (zh) | 2009-01-07 |
BRPI0618493A2 (pt) | 2011-08-30 |
MA30037B1 (fr) | 2008-12-01 |
WO2007058805A3 (en) | 2007-10-04 |
EP1959954A2 (en) | 2008-08-27 |
ZA200804951B (en) | 2009-04-29 |
IL191168A0 (en) | 2008-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200801302A1 (ru) | Композиции и способы лечения нарушений цнс | |
ATE475650T1 (de) | Positive allosterische chinolon-m1- rezeptormodulatoren | |
EA201071245A1 (ru) | Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
EA200700035A1 (ru) | Сульфаматные и сульфамидные производные для лечения эпилепсии и родственных di sorders | |
EA201170705A1 (ru) | Арилметилбензохиназолиноны в качестве позитивных аллостерических модуляторов рецептора м1 | |
EA200901373A1 (ru) | Аминогетероциклические соединения | |
EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
EA201170624A1 (ru) | Изоникотинамидные антагонисты рецепторов орексинов | |
EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
ATE530544T1 (de) | Benzyl-substituierte positive allosterische chinolon-m1-rezeptormodulatoren | |
MX2007009356A (es) | Compuestos y composiciones como moduladores de ppar. | |
TW200612926A (en) | Compounds and compositions as ppar modulators | |
MX336774B (es) | Moduladores alostericos positivos de receptores m1 de la quinolina amida. | |
EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
TW200602330A (en) | Compounds and compositions as PPAR modulators | |
EA200801481A1 (ru) | 5-(арилсульфонил)пиразолопиперидины | |
EA200801343A1 (ru) | Иммуноглобулины, направленные против nogo | |
DE602006017574D1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
EA200600071A1 (ru) | Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором | |
EA200701856A1 (ru) | Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении | |
ATE552257T1 (de) | Positive allosterische chinolizidinon-m1- rezeptormodulatoren | |
IL189974A0 (en) | Benzimidazole derivatives and their use for modulating the gabaa receptor complex | |
WO2009134668A3 (en) | 4-oxo-1,4-dihydroquinoline m1 receptor positive allosteric modulators |